BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 23688984)

  • 1. [Changes in gene expression profiles in multiple myeloma cells after knocking-down SNF5, a core subunit of SWI/SNF complex].
    Xie Y; Xu Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 May; 33(5):667-71. PubMed ID: 23688984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The SWI/SNF chromatin-remodeling complex subunit SNF5 is essential for hepatocyte differentiation.
    Gresh L; Bourachot B; Reimann A; Guigas B; Fiette L; Garbay S; Muchardt C; Hue L; Pontoglio M; Yaniv M; Klochendler-Yeivin A
    EMBO J; 2005 Sep; 24(18):3313-24. PubMed ID: 16138077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased DNA damage sensitivity and apoptosis in cells lacking the Snf5/Ini1 subunit of the SWI/SNF chromatin remodeling complex.
    Klochendler-Yeivin A; Picarsky E; Yaniv M
    Mol Cell Biol; 2006 Apr; 26(7):2661-74. PubMed ID: 16537910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple interactions of the oncoprotein transcription factor MYC with the SWI/SNF chromatin remodeler.
    Woodley CM; Romer AS; Wang J; Guarnaccia AD; Elion DL; Maxwell JN; Guerrazzi K; McCann TS; Popay TM; Matlock BK; Flaherty DK; Lorey SL; Liu Q; Tansey WP; Weissmiller AM
    Oncogene; 2021 May; 40(20):3593-3609. PubMed ID: 33931740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular senescence regulated by SWI/SNF complex subunits through p53/p21 and p16/pRB pathway.
    He L; Chen Y; Feng J; Sun W; Li S; Ou M; Tang L
    Int J Biochem Cell Biol; 2017 Sep; 90():29-37. PubMed ID: 28716547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of SNF5 expression correlates with poor patient survival in melanoma.
    Lin H; Wong RP; Martinka M; Li G
    Clin Cancer Res; 2009 Oct; 15(20):6404-11. PubMed ID: 19808872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic inactivation of the tumor suppressor BIN1 drives proliferation of SNF5-deficient tumors.
    McKenna ES; Tamayo P; Cho YJ; Tillman EJ; Mora-Blanco EL; Sansam CG; Koellhoffer EC; Pomeroy SL; Roberts CW
    Cell Cycle; 2012 May; 11(10):1956-65. PubMed ID: 22544318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SNF5/INI1 deficiency redefines chromatin remodeling complex composition during tumor development.
    Wei D; Goldfarb D; Song S; Cannon C; Yan F; Sakellariou-Thompson D; Emanuele M; Major MB; Weissman BE; Kuwahara Y
    Mol Cancer Res; 2014 Nov; 12(11):1574-85. PubMed ID: 25009291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SNF5, a core component of the SWI/SNF complex, is necessary for p53 expression and cell survival, in part through eIF4E.
    Xu Y; Yan W; Chen X
    Oncogene; 2010 Jul; 29(28):4090-100. PubMed ID: 20473326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The requirement for SNF5/INI1 in adipocyte differentiation highlights new features of malignant rhabdoid tumors.
    Caramel J; Medjkane S; Quignon F; Delattre O
    Oncogene; 2008 Mar; 27(14):2035-44. PubMed ID: 17922027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of the Snf5 tumor suppressor stimulates cell cycle progression and cooperates with p53 loss in oncogenic transformation.
    Isakoff MS; Sansam CG; Tamayo P; Subramanian A; Evans JA; Fillmore CM; Wang X; Biegel JA; Pomeroy SL; Mesirov JP; Roberts CW
    Proc Natl Acad Sci U S A; 2005 Dec; 102(49):17745-50. PubMed ID: 16301525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aurora A is a repressed effector target of the chromatin remodeling protein INI1/hSNF5 required for rhabdoid tumor cell survival.
    Lee S; Cimica V; Ramachandra N; Zagzag D; Kalpana GV
    Cancer Res; 2011 May; 71(9):3225-35. PubMed ID: 21521802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of PIH1D1 on the degradation of its binding protein SNF5].
    Zhai N; Zhang Y; Shen YF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Dec; 31(6):756-9. PubMed ID: 20078948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linking the SWI/SNF complex to prostate cancer.
    Lee RS; Roberts CW
    Nat Genet; 2013 Nov; 45(11):1268-9. PubMed ID: 24165726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of β-catenin/TCF targets following loss of the tumor suppressor SNF5.
    Mora-Blanco EL; Mishina Y; Tillman EJ; Cho YJ; Thom CS; Pomeroy SL; Shao W; Roberts CW
    Oncogene; 2014 Feb; 33(7):933-8. PubMed ID: 23435428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The functional role of the CARM1-SNF5 complex and its associated HMT activity in transcriptional activation by thyroid hormone receptor.
    Choi HK; Choi KC; Oh SY; Kang HB; Lee YH; Haam S; Ahn YH; Kim KS; Kim K; Yoon HG
    Exp Mol Med; 2007 Aug; 39(4):544-55. PubMed ID: 17934343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wongabel rhabdovirus accessory protein U3 targets the SWI/SNF chromatin remodeling complex.
    Joubert DA; Rodriguez-Andres J; Monaghan P; Cummins M; McKinstry WJ; Paradkar PN; Moseley GW; Walker PJ
    J Virol; 2015 Jan; 89(2):1377-88. PubMed ID: 25392228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of IGFBP7 expression and persistent AKT activation contribute to SMARCB1/Snf5-mediated tumorigenesis.
    Darr J; Klochendler A; Isaac S; Eden A
    Oncogene; 2014 Jun; 33(23):3024-32. PubMed ID: 23851500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetics and cancer: altered chromatin remodeling via Snf5 loss leads to aberrant cell cycle regulation.
    Sansam CG; Roberts CW
    Cell Cycle; 2006 Mar; 5(6):621-4. PubMed ID: 16582616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly penetrant, rapid tumorigenesis through conditional inversion of the tumor suppressor gene Snf5.
    Roberts CW; Leroux MM; Fleming MD; Orkin SH
    Cancer Cell; 2002 Nov; 2(5):415-25. PubMed ID: 12450796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.